Clinical trial No longer in our active list Interventional Ages 18 to 45

Measuring protein digestibility using a dual-isotope method

Official title: Validation of the Dual-isotope Method for Measuring Ileal Protein Digestibility

Run by Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · NCT05426551 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new way to measure how well healthy adults can digest protein from a special egg to see if it works better than traditional methods.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment36 (estimated)
SponsorInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Academic / other
Locations1 site (Bobigny)
Trial IDNCT05426551 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy men and women aged 18 to 45 with a BMI between 18 and 30.

Probably not a fit

Patients with any digestive or hepatic pathology, allergies to eggs or latex, or those who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the digestibility of indispensable amino acids (IAAs) from a specially prepared 2H-labeled hen's egg protein in healthy adults. Participants will consume a test meal containing the labeled protein, and the digestibility will be assessed using both indirect (dual isotope method) and direct (ileal digesta sampling) approaches. The study aims to validate the dual isotope method by comparing its results with direct measurements. A total of 18 healthy volunteers aged 18 to 45 will be recruited for this study, which will take place at the Human Nutrition Research Centre of Avicenne Hospital in France.

Why it matters

Potential benefit: If successful, this study could provide a reliable method for assessing protein digestibility, which may improve dietary recommendations and food formulations.

How similar studies have gone: While the dual isotope method has been recently developed, this study aims to validate its effectiveness, making it a novel approach in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18\<BMI\<30
* Healthy
* Insured under the French social security system
* For women: use of birth control
* Signed informed consent

Exclusion Criteria:

* Any dietary allergy
* Latex allergy
* Positive serology to HIV, hepatite C virus antibody, hepatite B virus surface antigen and core antibodies
* Gluten intolerance
* Anemia
* Use of drugs
* High consumption of alcohol
* Hypertension, diabetes, digestive disease, hepatic or renal disease, severe cardiac disease
* Pregnancy
* High sport practicing (\>7h/wk)
* Blood donation in the 3 months prior to the study
* Participation in a clinical study in the 3 months prior to the study
* No signed informed consent

Where it's running

  • Centre de Recherche sur Volontaires (CRV) de l'hôpital Avicenne
    Bobigny, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.